Skip to search.
 FTSE 100 Up 0.70%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
23.35 Up 4.91(26.63%) 25 May 21:00
|After Hours: : 23.06 Down 0.29 (1.24%) 00:59
Prev Close:18.44
Open:22.15
Bid:23.06 x 100
Ask:23.30 x 300
1y Target Est:17.92
Beta:1.32823
Earnings Date:4 Aug - 8 Aug (Est.)
Day's Range:20.83 - 23.72
52wk Range:8.00 - 41.97
Volume:21,352,147
Avg Vol (3m):5,867,390
Market Cap:1.07b
P/E (ttm):N/A
EPS (ttm):-5.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SRPT at this time.

Comparison

Symbol% ChgMkt Cap
SRPTUp 26.63%1.07b
GSKUp 0.96%104.74b
ALNYUp 9.93%5.44b
ISIS 0.00%6.91b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):673.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-4.54
Quarterly EPS Est (Jun-16) :-1.20
Mean Recommendation*:2.9
PEG Ratio (5 yr expected):20.30

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback